Baricitinib restrains the immune dysregulation in patients with severe COVID-19

Bronte V, Ugel S, Tinazzi E, Vella A, De Sanctis F, Canè S, Batani V, Trovato R, Fiore A, Petrova V, Hofer F, Barouni RM, Musiu C, Caligola S, Pinton L, Torroni L, Polati E, Donadello K, Friso S, Pizzolo F, Iezzi M, Facciotti F, Pelicci PG, Righetti D, Bazzoni P, Rampudda M, Comel A, Mosaner W, Lunardi C, Olivieri O.
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
J Clin Invest. 2020 Dec 1;130(12):6409-6416.
doi: 10.1172/JCI141772. PMID: 32809969; PMCID: PMC8016181